Toward a systematic understanding of cancers: A survey of the pan-cancer study

Frontiers in Genetics

Volumn 5, Issue JUL, 2014, Pages

  Liu, Zhaoqi ^a   Zhang, Shihua ^a  

^a CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Bioinformatics; Cancer genomics; Data integration; Pan cancer study; The cancer genome atlas

Indexed keywords

MICRORNA;

ARTICLE; CANCER GENETICS; COMPUTER ANALYSIS; COPY NUMBER VARIATION; DNA METHYLATION; GENE EXPRESSION; GENETIC ALGORITHM; GENETIC DATABASE; GENOMICS; HUMAN; PHOSPHORYLATION; SOMATIC MUTATION;

EID: 84906271624     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00194     Document Type: Article

References (47)

1. Akavia, U. D., Litvin, O., Kim, J., Sanchez-Garcia, F., Kotliar, D., Causton, H. C., et al. (2010). An integrated approach to uncover drivers of cancer. Cell 143, 1005-1017. doi: 10.1016/j.cell.2010.11.013
2. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A., Behjati, S., Biankin, A. V., et al. (2013). Signatures of mutational processes in human cancer. Nature 500, 415-421. doi: 10.1038/nature12477
3. Attolini, C. S. O., Cheng, Y. K., Beroukhim, R., Getz, G., Abdel-Wahab, O., Levine, R. L., et al. (2010). A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc. Natl. Acad. Sci. U.S.A. 107, 17604-17609. doi: 10.1073/pnas.1009117107
4. Bell, D., Berchuck, A., Birrer, M., Chien, J., Cramer, D. W., Dao, F., et al. (2011). Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615. doi: 10.1038/nature10166
5. Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., et al. (2010). The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905. doi: 10.1038/nature08822
6. Burns, M. B., Temiz, N. A., and Harris, R. S. (2013). Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 45, 977-983. doi: 10.1038/ng.2701
7. Ciriello, G., Cerami, E., Sander, C., and Schultz, N. (2012). Mutual exclusivity analysis identifies oncogenic network modules. Genome Res. 22, 398-406. doi: 10.1101/gr.125567.111
8. Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., and Sander, C. (2013). Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45, 1127-1133. doi: 10.1038/ng.2762
9. Cline, M. S., Craft, B., Swatloski, T., Goldman, M., Ma, S., Haussler, D., et al. (2013). Exploring TCGA pan-cancer data at the UCSC cancer genomics browser. Sci. Rep. 3:2652. doi: 10.1038/srep02652
10. Creighton, C. J., Morgan, M., Gunaratne, P. H., Wheeler, D. A., Gibbs, R. A., Muzny, D., et al. (2013). Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43-49. doi: 10.1038/nature12222
11. Gonzalez-Perez, A., Mustonen, V., Reva, B., Ritchie, G. R., Creixell, P., Karchin, R., et al. (2013a). Computational approaches to identify functional genetic variants in cancer genomes. Nat. Methods 10, 723-729. doi: 10.1038/nmeth.2562
12. Gonzalez-Perez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M. P., Jene-Sanz, A., et al. (2013b). IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10, 1081-1082. doi: 10.1038/nmeth.2642
13. Hamilton, M. P., Rajapakshe, K., Hartig, S. M., Reva, B., McLellan, M. D., Kandoth, C., et al. (2013). Identification of a pan-cancer oncogenic microRNA superfamily anchored by a central core seed motif. Nat. Commun. 4, 2730. doi: 10.1038/ncomms3730
14. Hammerman, P. S., Lawrence, M. S., Voet, D., Jing, R., Cibulskis, K., Sivachenko, A., et al. (2012). Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519-525. doi: 10.1038/nature11404
15. Hofree, M., Shen, J. P., Carter, H., Gross, A., and Ideker, T. (2013). Network-based stratification of tumor mutations. Nat. Methods 10, 1108-1115. doi: 10.1038/nmeth.2651
16. Jacobsen, A., Silber, J., Harinath, G., Huse, J. T., Schultz, N., and Sander, C. (2013). Analysis of microRNA-target interactions across diverse cancer types. Nat. Struct. Mol. Biol. 20, 1325-1332. doi: 10.1038/nsmb.2678
17. Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., et al. (2013a). Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339. doi: 10.1038/nature12634
18. Kandoth, C., Schultz, N., Cherniack, A. D., Akbani, R., Liu, Y., Shen, H., et al. (2013b). Integrated genomic characterization of endometrial carcinoma. Nature 497, 67-73. doi: 10.1038/nature12113
19. Kim, T. M., Xi, R., Luquette, L. J., Park, R. W., Johnson, M. D., and Park, P. J. (2013). Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res. 23, 217-227. doi: 10.1101/gr.140301.112
20. Koboldt, D. C., Fulton, R. S., McLellan, M. D., Schmidt, H., Kalicki-Veizer, J., McMichael, J. F., et al. (2012). Comprehensive molecular portraits of human breast tumors. Nature 490, 61-70. doi: 10.1038/nature11412
21. Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., et al. (2014). Discovery and saturation analysis of cancer genes across 21 tumor types. Nature 505, 495-501. doi: 10.1038/nature12912
22. Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., et al. (2013). Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218. doi: 10.1038/nature12213
23. Lee, G., Laflamme, E., Chien, C. H., and Ting, H. H. (2008). Molecular identity of a pan cancer marker, CA215. Cancer Biol. Ther. 7, 2007-2014. doi: 10.4161/cbt.7.12.6984
24. Li, J., Lu, Y., Akbani, R., Ju, Z., Roebuck, P. L., Liu, W., et al. (2013). TCPA: a resource for cancer functional proteomics data. Nat. Methods. 10, 1046-1047. doi: 10.1038/nmeth.2650
25. Li, W., Zhang, S., Liu, C. C., and Zhou, X. J. (2012). Identifying multi-layer gene regulatory modules from multi-dimensional genomic data. Bioinformatics 28, 2458-2466. doi: 10.1093/bioinformatics/bts476
26. Liu, Z., Zhang, X. S., and Zhang, S. (2014). Breast tumor subgroups reveal diverse clinical prognostic power. Sci. Rep. 4:4002. doi: 10.1038/srep04002
27. McLendon, R., Friedman, A., Bigner, D., Van Meir, E. G., Brat, D. J., Mastrogianakis, G. M., et al. (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068. doi: 10.1038/nature07385
28. Muzny, D. M., Bainbridge, M. N., Chang, K., Dinh, H. H., Drummond, J. A., Fowler, G., et al. (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 doi: 10.1038/nature11252
29. Omberg, L., Ellrott, K., Yuan, Y., Kandoth, C., Wong, C., Kellen, M. R., et al. (2013). Enabling transparent and collaborative computational analysis of 12 tumor types within the cancer genome atlas. Nat. Genet. 45, 1121-1126. doi: 10.1038/ng.2761
30. Reimand, J., and Bader, G. D. (2013). Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Mol. Syst. Biol. 9, 637. doi: 10.1038/msb.2012.68
31. Reimand, J., Wagih, O., and Bader, G. D. (2013). The mutational landscape of phosphorylation signaling in cancer. Sci Rep. 3:2651. doi: 10.1038/srep02651
32. Roberts, S. A., Lawrence, M. S., Klimczak, L. J., Grimm, S. A., Fargo, D., Stojanov, P., et al. (2013). An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970-976. doi: 10.1038/ng.2702
33. Sahin, U., Koslowski, M., Dhaene, K., Usener, D., Brandenburg, G., Seitz, G., et al. (2008). Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin. Cancer Res. 14, 7624-7634. doi: 10.1158/1078-0432.CCR-08-1547
34. Segal, E., Friedman, N., Koller, D., and Regev, A. (2004). A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090-1098. doi: 10.1038/ng1434
35. Tamborero, D., Gonzalez-Perez, A., Perez-Llamas, C., Deu-Pons, J., Kandoth, C., Reimand, J., et al. (2013). Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci. Rep. 3:2650. doi: 10.1038/srep02650
36. Tang, K. W., Alaei-Mahabadi, B., Samuelsson, T., Lindh, M., and Larsson, E. (2013). The landscape of viral expression and host gene fusion and adaptation in human cancer. Nat. Commun. 4, 2513. doi: 10.1038/ncomms3513
37. Vandin, F., Upfal, E., and Raphael, B. J. (2012). De novo discovery of mutated driver pathways in cancer. Genome Res. 22, 375-385. doi: 10.1101/gr.120477.111
38. Varley, K. E., Gertz, J., Bowling, K. M., Parker, S. L., Reddy, T. E., Pauli-Behn, F., et al. (2013). Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 23, 555-567. doi: 10.1101/gr.147942.112
39. Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., and Kinzler, K. W. (2013). Cancer genome landscapes. Science 339, 1546-1558. doi: 10.1126/science.1235122
40. Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., et al. (2013). The cancer genome atlas pan-cancer analysis project. Nat. Genet. 45, 1113-1120. doi: 10.1038/ng.2764
41. Wheeler, D. A., and Wang, L. (2013). From human genome to cancer genome: the first decade. Genome Res. 23, 1054-1062. doi: 10.1101/gr.157602.113
42. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., et al. (2010). Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 9, 1100-1117. doi: 10.1074/mcp.M900398-MCP200
43. Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., et al. (2013). Inferring tumor purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612. doi: 10.1038/ncomms3612
44. Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., et al. (2013). Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134-1140. doi: 10.1038/ng.2760
45. Zhang, S., Li, Q., Liu, J., and Zhou, X. J. (2011). A novel computational framework for simultaneous integration of multiple types of genomic data to identify microRNA-gene regulatory modules. Bioinformatics 27, i401-i409. doi: 10.1093/bioinformatics/btr206
46. Zhang, S., Liu, C. C., Li, W., Shen, H., Laird, P. W., and Zhou, X. J. (2012). Discovery of multi-dimensional modules by integrative analysis of cancer genomic data. Nucleic Acids Res. 40, 9379-9391. doi: 10.1093/nar/gks725
47. Zhao, J., Zhang, S., Wu, L. Y., and Zhang, X. S. (2012). Efficient methods for identifying mutated driver pathways in cancer. Bioinformatics 28, 2940-2947. doi: 10.1093/bioinformatics/bts564